Bionano Genomics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bionano Genomics, Inc. (BNGO) on May 23, 2019. The report discloses a specific financial event regarding the company's debt facilities. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
- Debt Activity: The company drew down $1.1 million on May 23, 2019.
- Facility Details: The drawdown was made under a $5.0 million revolving line of credit (the "Revolver").
- Interest Rate: Outstanding balances bear interest at 2.0% above the Bank's prime rate.
- Maturity Date: The Revolver matures on March 1, 2024.
- Revenue and Profit: The filing text does not provide a clear value for revenue, profit, cash flow, or margins.
Material Changes
The primary material change reported is the increase in outstanding debt under the Revolver by $1.1 million. This action was taken pursuant to the Loan and Security Agreement dated March 14, 2019. The filing does not provide comparative financial data to assess changes versus prior periods.
Outlook, Risks, and Contingencies
Repayment Terms: The company may repay and reborrow amounts under the Revolver at any time prior to maturity without penalty or premium. Amounts become immediately due and payable upon the March 1, 2024 maturity date.
Acceleration Risks: The obligation to repay is subject to acceleration upon the occurrence of specified events, including an event of default or a permitted prepayment of term loans borrowed under the Loan Agreement.
Management Commentary: The filing contains no forward-looking guidance or management commentary beyond the description of the loan terms.
Key Facts for Investor Verification
- Verify the total outstanding balance on the Revolver following the $1.1 million drawdown.
- Review the full Loan and Security Agreement (Exhibit 10.2 to the March 14, 2019 Form 8-K) for specific covenants and default triggers.
- Confirm the current prime rate to calculate the exact interest expense on the new drawdown.
- Assess the company's cash position to determine the necessity of this drawdown relative to operating needs.